FDA Biologics (BLA & Biosimilars)Original article
Procleix Ultrio Plus Assays
RegulatoryapprovedProcleix Ultrio Plus AssaysPositive
AI Analysis
Summary
Procleix Ultrio Plus Assays received FDA approval for use in screening organ donors from heart-beating and cadaveric donors, as well as testing blood specimens from living donors.
Outcome Details
FDA approval for use in testing plasma and serum specimens to screen organ donors and cadaveric donors, and testing individual samples from living donors
Importance:6/10
Sentiment:
0.70
FDA approvaldiagnosticorgan donor screeningblood screening
Read the original article
Published by FDA Biologics (BLA & Biosimilars) on July 8, 2026 4:34 PM